These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4150742)

  • 1. [Antihypertensive action of a beta-blocker: value of a controlled therapeutic trial].
    Safar M; Maiz HB; Weiss Y; Lagrue G; Milliez P
    Therapeutique; 1973; 49(7):459-62. PubMed ID: 4150742
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antihypertensive properties of a beta blocking agent, pindolol].
    Safar M; Weiss Y; Sobel A; Lagrue G; Milliez P
    Nouv Presse Med; 1973 Nov; 2(40):2685-8. PubMed ID: 4586561
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of 'responders' to long-term pindolol therapy from phasic changes in cardiovascular function during acute intravenous administration in essential hypertension.
    Logan AG; Milne BJ; Colman JM
    Clin Invest Med; 1978; 1(3-4):147-52. PubMed ID: 42504
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of arterial hypertension with a combination of pindolol and clopamide in long-term use (personal experience)].
    Sivacki J; Mostovac B; Uchytil R
    Lijec Vjesn; 1984; 106(11-12):509-12. PubMed ID: 6394938
    [No Abstract]   [Full Text] [Related]  

  • 5. A dose-finding study of the combination of pindolol, clopamide and endralazine in the treatment of moderate-to-severe hypertension.
    Seedat YK; Rawat R
    S Afr Med J; 1984 Nov; 66(18):682-4. PubMed ID: 6387966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial.
    Waal-Manning HJ; Simpson FO
    N Z Med J; 1974 Aug; 80(522):151-7. PubMed ID: 4608769
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative trial of fixed ratio beta-adrenoceptor blocker and diuretic combination products in moderate hypertension.
    Watt SJ; Lee MR
    Pharmatherapeutica; 1980; 2(7):487-93. PubMed ID: 6111083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term study of the antihypertensive effect of the pindolol and clopamide combination].
    Padovan GC; Gruppillo P; Masoni C; Tomaini MD
    G Ital Cardiol; 1981; 11(10):1456-9. PubMed ID: 7341315
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of LB 46 on the blood pressure in essential hypertension.
    Duner H
    Indian Heart J; 1972 Jun; 24():Suppl 1:236-7. PubMed ID: 4147279
    [No Abstract]   [Full Text] [Related]  

  • 10. [Should elderly hypertensive patients be treated with a beta-blocker-diuretic combination?].
    Böhmer F
    Z Gerontol; 1984; 17(2):89-92. PubMed ID: 6730636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of essential hypertension with pindolol and clopamide: problems arising from a combined beta blocker and diuretic therapy.
    Rosenfeld JB; Traub YM; Cohen L
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):786-97. PubMed ID: 4217245
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combination therapy of essential hypertension with beta receptor blockaders and diuretics].
    Rosenthal J; Meurer KA; Escobar-Jimenez F; Laaser U; Lang R; Raptis S
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():223-4. PubMed ID: 349926
    [No Abstract]   [Full Text] [Related]  

  • 13. [Angiotensin 1-antagonists: primary therapeutic option in arterial hypertension, too].
    Traut
    Dtsch Med Wochenschr; 2003 Jan; 128(4):161; discussion 161-2. PubMed ID: 12589590
    [No Abstract]   [Full Text] [Related]  

  • 14. New design for clinical trial of antihypertensive drugs applied to pindolol, clopamide, and combinations thereof.
    Nyberg G; Asplund J; Anagreus N; Aström B; Leppert J; Bergström R; Overmo J; Kullman S; Lessem J
    Lancet; 1982 Feb; 1(8268):355-8. PubMed ID: 6120347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of the combination of Pindolol and clopamide in systemic arterial hypertension. A multicenter study].
    Zilenovski AM; Freire CA
    Arq Bras Cardiol; 1981 Sep; 37(3):219-24. PubMed ID: 7052028
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of viskaldix in the treatment of patients with hypertension].
    Mikunis RI; Klipatskiĭ AA; Monastyrskiĭ IuI; Kirichenko VI; Pshelutskiĭ FF
    Klin Med (Mosk); 1988 Oct; 66(10):62-4. PubMed ID: 3070156
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
    Persson I; Ulrich J
    Ugeskr Laeger; 1973 May; 135(20):968-70. PubMed ID: 4755952
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect and tolerability of Viskaldix retard in ambulatory hypertensive patients].
    Kredel L
    Med Welt; 1984 Feb; 35(5):156-9. PubMed ID: 6366438
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydralazine and beta-adrenergic blockade in the treatment of hypertension.
    Siitonen L; Jänne J; Keyriläinen O; Koskinen P; Leskinen O; Pitkäjärvi T; Reinikainen M
    Ann Clin Res; 1974 Dec; 6(6):341-6. PubMed ID: 4155933
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of combined use of pindolol and clopamide on arterial blood pressure and blood and plasma volume in patients with primary arterial hypertension].
    Wyrzykowski B; Suchecka-Rachoń K
    Pol Arch Med Wewn; 1987; 77(1-2):25-30. PubMed ID: 3079499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.